Ono Pharmaceutical Co., Ltd.
[Ono Pharmaceutical] Share Buyback and Employee Stock Compensation System Introduction | June 2026
Ono Pharmaceutical plans to dispose of 20,900 shares and 179,000 shares of treasury stock on July 10, 2026, and allocate approximately 4.47 billion yen to shareholders and executives. The system aims for medium- to long-term corporate value enhancement and management motivation.
Key Figures
- Number of Shares Disposed: 20,900 shares (Employment Continuity Type)
- Number of Shares Disposed: 179,000 shares (Performance-Linked Type)
- Total Disposition Amount: Approximately 4.47 billion yen
AI要約
Details and Purpose of Disposition
Ono Pharmaceutical will dispose of 20,900 shares of treasury stock and 179,000 shares on July 10, 2026, allocating approximately 4.47 billion yen to directors. The plan includes a stock compensation system with employment continuity and performance-linked types, aiming to promote corporate value improvement and value sharing with shareholders. The disposed shares will be priced according to the market price to ensure fairness. The introduction of this system aims at enhancing long-term corporate value.
Overview of the System and Future Outlook
System I grants shares as consideration for employment continuity and job execution, with transfer restrictions during the restriction period. After the restriction expires, restrictions are解除 and, upon resignation or retirement, shares are acquired free of charge or restrictions are解除. System II is performance-linked, providing shares or cash based on performance evaluations. These systems aim to enhance long-term corporate value and shareholder value sharing, with ongoing operation and improvements expected in the future.
Ono Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
